Article info

Download PDFPDF
Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis
  1. Correspondence to Dr Michael P T Lunn, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK; michael.lunn{at}uclh.org
View Full Text

Citation

Sadnicka A, Reilly MM, Mummery C, et al
Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis

Publication history

  • Received May 4, 2009
  • Revised August 12, 2009
  • Accepted August 27, 2009
  • First published May 12, 2010.
Online issue publication 
January 05, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.